Abstract Background Coronavirus disease-2019 (COVID-19) is characterized by a
dysfunctional immune response and abnormal blood rheology that contribute to endothelial …

Background Increased estimated whole blood viscosity (eWBV) predicts higher mortality in
patients hospitalized for coronavirus disease 2019 (COVID-19). This study assesses …

BACKGROUND: Elevated estimated blood viscosity (EBV), derived from hematocrit and
globulins, is associated with thrombotic complications, organ failure, and higher mortality in …

Coronavirus disease 2019 (COVID-19) is caused by a novel virus known as severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2-induced …

Background Recent data suggests an association between blood hyperviscosity and both
propensity for thrombosis and disease severity in patients with COVID‐19. This raises the …

Abstract Background Coronavirus disease 2019 (COVID‐19) interferes with the vascular
endothelium. It is not known whether COVID‐19 additionally affects arterial stiffness …

Background Several studies have evaluated the possible association between whole blood
viscoelastic testing (VET) parameters in patients hospitalized for acute Coronavirus disease …

Blood plasma is a large reservoir of circulating mediators of inflammation and its expansion
has been associated with unfavorable outcomes in patients with inflammatory and …

Background The novel coronavirus disease (COVID-19) may cause vascular (eg,
endothelial dysfunction, and arterial stiffness), cardiac, autonomic (eg, heart rate variability …

Although COVID-19 begins as a respiratory pneumonia, we are now discovering it causes
an intense inflammatory response accompanied by systemic microangiopathy. In reflecting …